Questions about AstraZeneca jab linger

Peru registers highest daily COVID-19 death toll
4 April 2021
New study shows how online endorsement could help address COVID-19 vaccine hesitancy
5 April 2021

Questions about AstraZeneca jab linger

Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against COVID-19 are more frequent than in the general population, and what causes them if they are, have continued to undermine confidence in the beleaguered vaccine.

Comments are closed.